Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -42,128 | -30,004 | -8,846 | -39,366 | -26,282 |
| Depreciation Amortization | 1,720 | 1,124 | 570 | 2,333 | 1,585 |
| Accounts receivable | -10 | 227 | -200 | -620 | -849 |
| Accounts payable and accrued liabilities | -2,342 | -1,651 | 122 | 7,444 | 5,306 |
| Other Working Capital | -2,860 | -868 | 293 | 6,188 | 4,653 |
| Other Operating Activity | 25,571 | 18,230 | 1,237 | -766 | -1,158 |
| Operating Cash Flow | $-20,049 | $-12,942 | $-6,824 | $-24,787 | $-16,745 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,827 | 8,920 | 5,537 | -8,908 | -12,642 |
| PPE Investments | -290 | -36 | -19 | -534 | -550 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 124 |
| Investing Cash Flow | $8,537 | $8,884 | $5,518 | $-9,442 | $-13,068 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13,780 | 6,632 | 34 | 45,690 | 44,873 |
| Other Financing Activity | -67 | -36 | 0 | 0 | -2 |
| Financing Cash Flow | $13,713 | $6,596 | $34 | $45,690 | $44,871 |
| Exchange Rate Effect | 695 | 87 | 378 | -1,013 | 571 |
| Beginning Cash Position | 16,871 | 16,871 | 16,871 | 6,423 | 6,217 |
| End Cash Position | 19,767 | 19,496 | 15,977 | 16,871 | 21,846 |
| Net Cash Flow | $2,896 | $2,625 | $-894 | $10,448 | $15,629 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,049 | -12,942 | -6,824 | -24,787 | -16,745 |
| Capital Expenditure | -290 | -36 | -19 | -534 | -550 |
| Free Cash Flow | -20,339 | -12,978 | -6,843 | -25,321 | -17,295 |